2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[2-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide

C106H85F3N24Pt4 — CID 159944813

About 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[2-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide

2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[2-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide (PubChem CID 159944813) has the molecular formula C106H85F3N24Pt4 and a molecular weight of 2532.32 g/mol. Its IUPAC name is 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[2-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide.

Molecular Properties

• Compound Name: 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[2-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide
• PubChem CID: 159944813
• Molecular Formula: C106H85F3N24Pt4
• Molecular Weight: 2532.32 g/mol
• Exact Mass: 2530.59
• IUPAC Name: 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[2-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide
• SMILES: CCc1n[n-]c(-c2cccc(-c3ccccc3-c3cccc(-c4[n-]nc(CC)c4C)n3)n2)c1C.Cc1cc(-c2cccc(-c3ccccc3-c3cccc(-c4cc(C(F)(F)F)n[n-]4)n3)n2)[n-]n1.Cc1cc(-c2cccc(-c3ccccc3-c3cccc(-c4cc(C)n[n-]4)n3)n2)[n-]n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].c1cc(-c2ccccc2-c2cccc(-c3[n-]nc4c3CCCC4)n2)nc(-c2[n-]nc3c2CCCC3)c1
• InChI: InChI=1S/C30H26N6.C28H26N6.C24H15F3N6.C24H18N6.4Pt/c1-2-10-20(24-16-8-18-28(32-24)30-22-12-4-6-14-26(22)34-36-30)19(9-1)23-15-7-17-27(31-23)29-21-11-3-5-13-25(21)33-35-29;1-5-21-17(3)27(33-31-21)25-15-9-13-23(29-25)19-11-7-8-12-20(19)24-14-10-16-26(30-24)28-18(4)22(6-2)32-34-28;1-14-12-21(31-30-14)19-10-4-8-17(28-19)15-6-2-3-7-16(15)18-9-5-11-20(29-18)22-13-23(33-32-22)24(25,26)27;1-15-13-23(29-27-15)21-11-5-9-19(25-21)17-7-3-4-8-18(17)20-10-6-12-22(26-20)24-14-16(2)28-30-24;;;;/h1-2,7-10,15-18H,3-6,11-14H2;7-16H,5-6H2,1-4H3;2-13H,1H3;3-14H,1-2H3;;;;/q4*-2;4*+2
• InChIKey: OBIUDFUKUFQIFS-UHFFFAOYSA-N
• XLogP: 20.83
• TPSA: 319.04 Ų
• H-Bond Acceptors: 16
• Rotatable Bonds: 18
• Heavy Atoms: 137
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2532.32
LogP ≤ 5	20.83
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	16

Frequently Asked Questions

What is the IUPAC name of 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[2-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide?

The IUPAC name of 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[2-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide (CID 159944813) is 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[2-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide.

What is the SMILES notation for 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[2-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide?

The canonical SMILES for 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[2-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide is CCc1n[n-]c(-c2cccc(-c3ccccc3-c3cccc(-c4[n-]nc(CC)c4C)n3)n2)c1C.Cc1cc(-c2cccc(-c3ccccc3-c3cccc(-c4cc(C(F)(F)F)n[n-]4)n3)n2)[n-]n1.Cc1cc(-c2cccc(-c3ccccc3-c3cccc(-c4cc(C)n[n-]4)n3)n2)[n-]n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].c1cc(-c2ccccc2-c2cccc(-c3[n-]nc4c3CCCC4)n2)nc(-c2[n-]nc3c2CCCC3)c1.

What is the InChIKey of 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[2-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide?

The InChIKey is OBIUDFUKUFQIFS-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H26N6.C28H26N6.C24H15F3N6.C24H18N6.4Pt/c1-2-10-20(24-16-8-18-28(32-24)30-22-12-4-6-14-26(22)34-36-30)19(9-1)23-15-7-17-27(31-23)29-21-11-3-5-13-25(21)33-35-29;1-5-21-17(3)27(33-31-21)25-15-9-13-23(29-25)19-11-7-8-12-20(19)24-14-10-16-26(30-24)28-18(4)22(6-2)32-34-28;1-14-12-21(31-30-14)19-10-4-8-17(28-19)15-6-2-3-7-16(15)18-9-5-11-20(29-18)22-13-23(33-32-22)24(25,26)27;1-15-13-23(29-27-15)21-11-5-9-19(25-21)17-7-3-4-8-18(17)20-10-6-12-22(26-20)24-14-16(2)28-30-24;;;;/h1-2,7-10,15-18H,3-6,11-14H2;7-16H,5-6H2,1-4H3;2-13H,1H3;3-14H,1-2H3;;;;/q4*-2;4*+2.

What are the key properties of 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[2-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide?

2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[2-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide has a molecular weight of 2532.32 g/mol, XLogP of 20.83, 18 rotatable bonds, 0 hydrogen bond donors, and 16 hydrogen bond acceptors.

Where does this data come from?

All data for 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[2-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[2-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide is sourced from PubChem (CID 159944813), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).